Adherence Monitoring For Substance Abuse Clinical Trials

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01867476

Enrollment

Registered

2013-06-04

Start date

2013-01-31

Completion date

2013-02-28

Last updated

2013-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Adherence

Brief summary

The purpose of this study is to determine the feasibility and accuracy of an automated adherence monitoring system, and to compare the variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval.

Interventions

OTHERAutomated Adherence Monitoring System

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* Male or female, aged 18 to 60 * Ability to give informed consent. * Be willing and able to use the study-provided phone for taking and transmitting capsule photos.

Exclusion criteria

* Unwilling or unable to use a cell phone. * Any medical, psychiatric, or other condition that, in the opinion of the investigator, would preclude safe, consistent, or useful participation in the study.

Design outcomes

Primary

Measure	Time frame
Variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval	+ 1, 2, 3, 4, 6 hours post dose

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026